Skip to main content
. 2020 Jul 16;10:11842. doi: 10.1038/s41598-020-68804-7

Figure 5.

Figure 5

Administration of recombinant progranulin decreased deterioration of cardiac dysfunction after myocardial ischemia–reperfusion injury in rabbits. (A) The positive values of the first derivative in left ventricular pressure (dP/dt) and (B) the negative dP/dt were determined by cardiac catheterization 2 weeks after myocardial ischemia/reperfusion (I/R). (C) Left ventricular internal diameter at diastole (LVIDd), (D) left ventricular internal diameter at systole (LVIDs), (E) ejection fraction (EF), and (F) fractional shortening (FS) were measured by echocardiography analysis. The administration of recombinant progranulin significantly ameliorated the deterioration of + dP/dt, LVIDd, LVIDs, EF and FS compared with vehicle-treated group. Data are the means ± SEM. (n = 3–7) *p < 0.05 versus vehicle-treated group (A, B; two-tailed Student's t-test, CF; one-tailed Student's t-test).